(19)
(11) EP 4 771 002 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24773646.5

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
C07D 403/14(2006.01)
C07D 413/14(2006.01)
C07D 487/04(2006.01)
C07D 519/00(2006.01)
A61K 31/437(2006.01)
A61K 31/519(2006.01)
C07D 407/14(2006.01)
C07D 471/04(2006.01)
C07D 491/044(2006.01)
A61P 35/00(2006.01)
A61K 31/513(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 487/04; C07D 471/04; C07D 519/00; C07D 413/14; C07D 403/14; C07D 407/14; C07D 491/044; A61P 35/00
(86) International application number:
PCT/US2024/044766
(87) International publication number:
WO 2025/049976 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.08.2023 US 202363579538 P

(71) Applicant: Oncopia Therapeutics, Inc. D/B/A SK Life Science Labs
King of Prussia, PA 19406 (US)

(72) Inventors:
  • ROACH, Jeremy
    King of Prussia, Pennsylvania 19406 (US)
  • ZHANG, Xuqing
    King of Prussia, Pennsylvania 19406 (US)

(74) Representative: Haseltine Lake Kempner LLP 
Cheapside House 138 Cheapside
London EC2V 6BJ
London EC2V 6BJ (GB)

   


(54) COMPOUNDS AND COMPOSITIONS AS CBP/P300 DEGRADERS AND USES THEREOF